Back to Search
MARTIN FARLOW, MD
MD
Neurology Physician
NPI: 1508880022IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
01029454A(IN)
CMS Specialties
PrimaryNEUROLOGY
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 1979
Research & Publications (20)
Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials.
PMID 18558791·Drug Saf·2008
8-other
Treatment options in Alzheimer's disease: maximizing benefit, managing expectations.
PMID 18391487·Dement Geriatr Cogn Disord·2008
6-review
Randomized clinical trial results for donepezil in Alzheimer's disease: is the treatment glass half full or half empty?
PMID 18808602·J Am Geriatr Soc·2008
8-other
A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
PMID 18311077·Dement Geriatr Cogn Disord·2008
4-observational
Rivastigmine three times daily improves cognition and response in Alzheimer's disease.
PMID 17962669·Evid Based Ment Health·2007
8-other
Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
PMID 17036561·Mayo Clin Proc·2006
6-review
Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis.
PMID 16088144·Dement Geriatr Cogn Disord·2005
1-meta
Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years.
PMID 15659242·BMC Geriatr·2005
2-rct
Differential qualitative responses to rivastigmine in APOE epsilon 4 carriers and noncarriers.
PMID 15289797·Pharmacogenomics J·2004
4-observational
Utilizing combination therapy in the treatment of Alzheimer's disease.
PMID 15853507·Expert Rev Neurother·2004
6-review
NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.
PMID 15224791·Geriatrics·2004
6-review
Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
PMID 12810489·Arch Neurol·2003
3-trial
A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
PMID 12636182·Int Psychogeriatr·2002
4-observational
Do cholinesterase inhibitors slow progression of Alzheimer's disease?
PMID 12139366·Int J Clin Pract Suppl·2002
6-review
Cholinesterase inhibitors: relating pharmacological properties to clinical profiles: Introduction.
PMID 12139364·Int J Clin Pract Suppl·2002
6-review
Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine.
PMID 11396867·Clin Ther·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 550 UNIVERSITY BLVD
INDIANAPOLIS, IN 46202 - Phone
- (317) 274-8800
Quick Facts
- NPI
- 1508880022
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile